Wikidata

(Q63833350)

English

Bevacizumab in Recurrent Grade II and III Glioma

clinical trial

In more languages

Statements

short name
TAVAREC (English)
0 references
title
Randomized Trial Assessing the Significance of Bevacizumab in Recurrent Grade II and Grade III Gliomas - The TAVAREC Trial (English)
0 references
medical condition
glioma
0 references
country
Austria
0 references
Belgium
0 references
France
0 references
Germany
0 references
Italy
0 references
Netherlands
0 references
Switzerland
0 references
United Kingdom
0 references
start time
February 2011
0 references
end time
19 January 2017
0 references
number of participants
155
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63833350&oldid=1857455663"